VF
AMLX icon

Virtu Financial’s Amylyx Pharmaceuticals AMLX Stock Holding History

Virtu Financial’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-27,715
Closed -$408K – 1372
2023
Q4 		$408K Buy
+27,715
New +$425K 0.03% 476
2023
Q3 		– Sell
-17,742
Closed -$383K – 1262
2023
Q2 		$383K Sell
17,742
-519
-3% -$14K 0.03% 503
2023
Q1 		$536K Buy
+18,261
New +$634K 0.06% 323
2022
Q3 		– Sell
-36,003
Closed -$693K – 1692
2022
Q2 		$693K Buy
+36,003
New +$427K 0.06% 289

Other funds holding AMLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu Financial's AMLX Position: Q1 2024 in Review

Virtu Financial sold out of Amylyx Pharmaceuticals (AMLX) in Q1 2024, closing a stake of 27,715 shares — an estimated $408K sold.

Virtu Financial first reported a position in AMLX in Q2 2022 and held it in 4 quarters. The position peaked at $693K in Q2 2022. 143 funds tracked by Wall St. Rank hold AMLX as of Q1 2024.

  • Virtu Financial reported no remaining Amylyx Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 27,715 Amylyx Pharmaceuticals shares in Q1 2024, an estimated $408K.
  • Virtu Financial first reported a position in Amylyx Pharmaceuticals in Q2 2022 and held it in 4 quarters.
  • Virtu Financial's Amylyx Pharmaceuticals position peaked at $693K in Q2 2022.
  • 143 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.